415
Participants
Start Date
October 26, 2018
Primary Completion Date
March 5, 2020
Study Completion Date
January 22, 2021
MT10109L
MT10109Lwill be injected into either the Glabellar Lines (GL), Lateral Canthal Lines (LCL), or both.
Placebo
Placebo will be injected into either the Glabellar Lines (GL), Lateral Canthal Lines (LCL), or both.
Laser & Skin Surgery Center of New York, New York
RZANY & HUND - Privatpraxis fur Dermatologie und Asthetische Medizin, Berlin
MD Laser, Skin, & Vein Institute, Hunt Valley
SkinDC, Arlington
Virginia Clinical Research, Inc., Norfolk
Skin Research Institute LLC, Coral Gables
DRK-Kliniken Nordhessen, Kassel
Privatpraxis Dr. Hilton & Partner, Düsseldorf
Coleman Center for Cosmetic Dermatologic Surgery, Metairie
Bellaire Dermatology Associates, Bellaire
Studienzentrum Theatiner46, Munich
Advanced Research Associates, Glendale
Eye Research Foundation, Newport Beach
Dr. Shannon Humphrey Inc., Vancouver
Project Skin MD, Vancouver
Sweat Clinics of Canada, Toronto
Bertucci MedSpa Inc., Woodbridge
Saleh Aesthetic Clinic Ltd., Cheadle
Cranley Clinic, London
Bermuda Practice, Basingstoke
Meyer Clinic, Chichester
Medy-Tox
INDUSTRY